From the Department of Orthopaedic Surgery, Hand and Upper Extremity, Foot and Ankle, and Orthopaedic Oncology Services, the Harvard Medical School Orthopedic Trauma Initiative, and the Division of Plastic Surgery, Hand Surgery, and Peripheral Nerve Surgery, Massachusetts General Hospital, Harvard Medical School.
Plast Reconstr Surg. 2022 Aug 1;150(2):446-455. doi: 10.1097/PRS.0000000000009334. Epub 2022 Jul 27.
Lower extremity amputations are common, and postoperative neuropathic pain (phantom limb pain or symptomatic neuroma) is frequently reported. The use of active treatment of the nerve end has been shown to reduce pain but requires additional resources and should therefore be performed primarily in high-risk patients. The aim of this study was to identify the factors associated with the development of neuropathic pain following above-the-knee amputation, knee disarticulation, or below-the-knee amputation.
Retrospectively, 1565 patients with an average follow-up of 4.3 years who underwent a primary above-the-knee amputation, knee disarticulation, or below-the-knee amputation were identified. Amputation levels for above-the-knee amputations and knee disarticulations were combined as proximal amputation level, with below-the-knee amputations being performed in 61 percent of patients. The primary outcome was neuropathic pain (i.e., phantom limb pain or symptomatic neuroma) based on medical chart review. Multivariable logistic regression was performed to identify independent factors associated with neuropathic pain.
Postoperative neuropathic pain was present in 584 patients (37 percent), with phantom limb pain occurring in 34 percent of patients and symptomatic neuromas occurring in 3.8 percent of patients. Proximal amputation level, normal creatinine levels, and a history of psychiatric disease were associated with neuropathic pain. Diabetes, hypothyroidism, and older age were associated with lower odds of developing neuropathic pain.
Neuropathic pain following lower extremity amputation is common. Factors influencing nerve regeneration, either increasing (proximal amputations and younger age) or decreasing (diabetes, hypothyroidism, and chronic kidney disease) it, play a role in the development of postamputation neuropathic pain.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
下肢截肢很常见,术后常出现神经性疼痛(幻肢痛或症状性神经瘤)。已证实,积极治疗神经末梢可减轻疼痛,但需要额外的资源,因此主要应在高风险患者中进行。本研究旨在确定与膝上截肢、膝关节离断或膝下截肢后神经性疼痛发展相关的因素。
回顾性分析了 1565 例平均随访 4.3 年的初次膝上截肢、膝关节离断或膝下截肢患者。膝上截肢和膝关节离断的截肢水平合并为近端截肢水平,61%的患者接受了膝下截肢。主要结局是根据病历回顾确定的神经性疼痛(即幻肢痛或症状性神经瘤)。采用多变量逻辑回归分析确定与神经性疼痛相关的独立因素。
584 例(37%)患者术后出现神经性疼痛,34%的患者出现幻肢痛,3.8%的患者出现症状性神经瘤。近端截肢水平、正常肌酐水平和精神病史与神经性疼痛相关。糖尿病、甲状腺功能减退症和年龄较大与发生神经性疼痛的几率降低相关。
下肢截肢后出现神经性疼痛很常见。影响神经再生的因素,无论是增加(近端截肢和较年轻)还是减少(糖尿病、甲状腺功能减退症和慢性肾脏病),都与截肢后神经性疼痛的发展有关。
临床问题/证据水平:风险,III 级。